Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-05 · accession 0001628280-22-018607 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-07-06 | 2022-07-05 | CRDF | White Lale | Dir | M - OptEx | $2.60 | +28.9K | 98.8K | +41% | +$75.0K |
| D | 2022-07-06 | 2022-07-05 | CRDF | White Lale | Dir | M - OptEx | $2.60 | -28.9K | 60.7K | -32% | -$75.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-05 | M | A | 28,858 | $2.60 | 98,788 | I Trust | — | — | |
| 2 | Derivative | Stock Options | 2022-07-05 | M | D | 28,858 | $2.60 | 60,716 | D | $2.60 · 2021-06-17 to 2030-06-17 | 28,858 Common Stock |